These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38410545)

  • 1. Suppression of ZNF205-AS1/EGR4 positive feedback loop attenuates cisplatin resistance of non-small cell lung cancer cells via targeting miR-138-5p/OCT4 pathway.
    Li H; Jin Y; Zhu Y; Shen B; Xu Y
    J Thorac Dis; 2024 Jan; 16(1):296-310. PubMed ID: 38410545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A positive feedback loop between ZNF205-AS1 and EGR4 promotes non-small cell lung cancer growth.
    He S; Lin J; Xu Y; Lin L; Feng J
    J Cell Mol Med; 2019 Feb; 23(2):1495-1508. PubMed ID: 30556283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. lncRNA
    Ge P; Cao L; Yao YJ; Jing RJ; Wang W; Li HJ
    Onco Targets Ther; 2019; 12():6105-6117. PubMed ID: 31534348
    [No Abstract]   [Full Text] [Related]  

  • 4. Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis.
    Feng N; Guo Z; Wu X; Tian Y; Li Y; Geng Y; Yu Y
    Respir Res; 2021 Sep; 22(1):248. PubMed ID: 34537072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3/SOX2 axis.
    Xie H; Yao J; Wang Y; Ni B
    Drug Deliv; 2022 Dec; 29(1):1257-1271. PubMed ID: 35467477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of Long Non-Coding RNA
    Zhan Y; Abuduwaili K; Wang X; Shen Y; Nuerlan S; Liu C
    Cancer Manag Res; 2020; 12():7725-7737. PubMed ID: 32943921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA FOXD3-AS1 promoted chemo-resistance of NSCLC cells via directly acting on miR-127-3p/MDM2 axis.
    Zeng Z; Zhao G; Zhu H; Nie L; He L; Liu J; Li R; Xiao S; Hua G
    Cancer Cell Int; 2020; 20():350. PubMed ID: 32742197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis.
    Ge P; Cao L; Zheng M; Yao Y; Wang W; Chen X
    Exp Mol Pathol; 2021 Jun; 120():104633. PubMed ID: 33753110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-125b-5p upregulation by TRIM28 induces cisplatin resistance in non-small cell lung cancer through CREB1 inhibition.
    Tan Q; Ma J; Zhang H; Wu X; Li Q; Zuo X; Jiang Y; Liu H; Yan L
    BMC Pulm Med; 2022 Dec; 22(1):469. PubMed ID: 36476351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mir-126-5p Promotes Cisplatin Sensitivity of Non-Small-Cell Lung Cancer by Inhibiting ADAM9.
    Liu B; Wang R; Liu H
    Biomed Res Int; 2021; 2021():6622342. PubMed ID: 34055989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296-5p.
    Dong Y; Xu T; Zhong S; Wang B; Zhang H; Wang X; Wang P; Li G; Yang S
    Life Sci; 2019 Dec; 239():116984. PubMed ID: 31647948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA NNT-AS1 is a major mediator of cisplatin chemoresistance in non-small cell lung cancer through MAPK/Slug pathway.
    Cai Y; Dong ZY; Wang JY
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4879-4887. PubMed ID: 30070323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-186-5p targeting SIX1 inhibits cisplatin resistance in non-small-cell lung cancer cells (NSCLCs).
    Liu X; Zhou X; Chen Y; Huang Y; He J; Luo H
    Neoplasma; 2020 Jan; 67(1):147-157. PubMed ID: 31686523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hsa_circ_0017639 regulates cisplatin resistance and tumor growth via acting as a miR-1296-5p molecular sponge and modulating sine oculis homeobox 1 expression in non-small cell lung cancer.
    Chang F; Li J; Sun Q; Wei S; Song Y
    Bioengineered; 2022 Apr; 13(4):8806-8822. PubMed ID: 35287543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-139-5p Targetedly Regulates YAF2 and Mediates the AKT/P38 MAPK Signaling Pathway to Alleviate the Metastasis of Non-Small Cell Lung Cancer Cells and Their Resistance Against Cisplatin.
    Yan Y; Jin X; Sun H; Pang S; Kong X; Bu J; Xu S
    Cancer Manag Res; 2021; 13():3639-3650. PubMed ID: 33981163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of FGD5-AS1 contributes to cell progression by improving cisplatin resistance against non-small cell lung cancer cells through regulating miR-140-5p/WEE1 axis.
    Fu J; Cai H; Wu Y; Fang S; Wang D
    Gene; 2020 Sep; 755():144886. PubMed ID: 32534055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Long Non-coding RNA, MSTRG.51053.2 Regulates Cisplatin Resistance by Sponging the miR-432-5p in Non-small Cell Lung Cancer Cells.
    Zhang J; Xu C; Gao Y; Wang Y; Ding Z; Zhang Y; Shen W; Zheng Y; Wan Y
    Front Oncol; 2020; 10():215. PubMed ID: 32158694
    [No Abstract]   [Full Text] [Related]  

  • 18. TP53 mitigates cisplatin resistance in non-small cell lung cancer by mediating the effects of resistant cell-derived exosome mir-424-5p.
    Deng Y; Ding H; Zhang Y; Feng X; Ye Q; Tian R; Xu Y; He Q; Fu Q; Li R
    Heliyon; 2024 Mar; 10(5):e26853. PubMed ID: 38439876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA SNHG12 Decreases Non-Small Cell Lung Cancer Cell Sensitivity to Cisplatin by Repressing miR-525-5p and Promoting XIAP.
    Tan D; Wang S; Zhang P; Peng C; Wu T
    Ann Clin Lab Sci; 2023 Jan; 53(1):64-75. PubMed ID: 36889771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-96-5p regulates cervical cancer cell resistance to cisplatin by inhibiting lncRNA TRIM52-AS1 and promoting IGF2BP2.
    Wu EY; Huang LP; Bao JH
    Kaohsiung J Med Sci; 2022 Dec; 38(12):1178-1189. PubMed ID: 36354205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.